AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q2 2022

Top Holdings2,173 positions

Checking export access…
Activity:

Apple Inc.

9.9M$1.3B3.0%$38.00+252.37%
15 qtrssince 2018-Q4
Decreased
0

Microsoft Corp.

4.7M$1.2B2.7%$94.43+162.64%
15 qtrssince 2018-Q4
Decreased
0

Alphabet Inc.

287,729$619.8M1.4%$52.33+106.28%
15 qtrssince 2018-Q4
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MFG LTD

6.8M$557.4M1.3%$39.53+93.65%
15 qtrssince 2018-Q4
Decreased
0

PFIZER INC

10.6M$553.9M1.3%$34.72+18.79%
15 qtrssince 2018-Q4
Decreased
0

Meta Platforms Inc

2.7M$437.5M1.0%$167.35-4.56%
15 qtrssince 2018-Q4
Decreased
0

EXXON MOBIL CORP

4.4M$377.6M0.9%$58.32+33.01%
15 qtrssince 2018-Q4
Increased
61

GILEAD SCIENCES INC

6.1M$375.6M0.8%$52.07+2.90%
15 qtrssince 2018-Q4
Increased
71

The Procter & Gamble Co.

2.6M$375.6M0.8%$83.49+54.08%
15 qtrssince 2018-Q4
Decreased
0

Merck & Co., Inc

4.1M$375.2M0.8%$60.87+31.98%
15 qtrssince 2018-Q4
Increased
50

Johnson & Johnson

2.1M$369.8M0.8%$105.61+49.03%
15 qtrssince 2018-Q4
Decreased
0

Amazon.com, Inc.

3.5M$366M0.8%$90.79+16.99%
15 qtrssince 2018-Q4
Increased
71

Alphabet Inc.

164,112$359M0.8%$51.55+110.19%
15 qtrssince 2018-Q4
Decreased
0

PEPSICO INC

2M$340.8M0.8%$104.64+38.20%
15 qtrssince 2018-Q4
Increased
46

REGENERON PHARMACEUTICALS

550,416$323.2M0.7%$556.71+5.19%
15 qtrssince 2018-Q4
Increased
47

CVS HEALTH CORP

3.4M$312.7M0.7%$73.88+7.99%
15 qtrssince 2018-Q4
Increased
70

UnitedHealth Group Inc.

600,297$307.9M0.7%$239.49+97.86%
15 qtrssince 2018-Q4
Decreased
0

Cisco Systems, Inc.

6.9M$291.7M0.7%$38.20-1.03%
15 qtrssince 2018-Q4
Increased
50

TYSON FOODS INC

3.2M$278.4M0.6%$63.39+17.60%
15 qtrssince 2018-Q4
Increased
68

ARROW ELECTRS INC

2.5M$269.6M0.6%$76.89+45.78%
15 qtrssince 2018-Q4
Increased
47
$44.2B
AUM
2,173
Positions
Q2 2022
Filing
HI score · 2.0/5
Quarterly 13F Value Change
+8%Q1'21$61.1B-5%Q2'21$57.8B-7%Q3'21$53.9B+2%Q4'21$55.2B-4%Q1'22$52.7B-16%Q2'22$44.2B
Activity profile
$ moved · Q2'22
New1%Increased32%Decreased66%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 years
<1Q3%1-4Q6%1-2Y9%2Y+82%

AQR CAPITAL MANAGEMENT LLC manages $44.2B across 2173 positions as of Q2 2022. Top holdings: AAPL (3.0%), MSFT (2.7%), GOOGL (1.4%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2/5.0.

Q2 2022 Summary

Active quarter - 158 new positions, 193 exits, 1006 increased. Top move: GILD (INCREASED, conviction 71). Portfolio: $44.2B across 2173 positions.

Top holdings by portfolio weight

Total AUM$44B
AAPL3.01%
MSFT2.70%
GOOGL1.40%
TSM1.26%
PFE1.25%
META0.99%
XOM0.85%
GILD0.85%
PG0.85%
MRK0.85%
Other0.84%

Portfolio allocation by GICS sector

Sectors11
Technology19.91%
Healthcare15.94%
Financial Services11.55%
Industrials11.26%
Consumer Cyclical10.54%
Consumer Defensive8.15%
Communication Services5.33%
Energy4.21%
Basic Materials4.00%
Unknown3.41%
Other5.71%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L51
Conviction42
Concentration18
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
AGNCAGNCAGNC INVT CORP
Q4 2024 → Q2 2026+320,621 shares+$3.5M
7Q
AKBAAKBAAKEBIA THREAPEUTICS INC COM
Q4 2024 → Q2 2026+9M shares+$10.2M
7Q
ALRMALRMALARM COM HLDGS INC
Q4 2024 → Q2 2026+213,814 shares+$9.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used